SkinnyRx review

SkinnyRx does one thing better than most of this ranking and one thing worse. The better thing is disclosure of terms: every rung on every product is on the page before you answer a single medical question, there is no quiz wall between you and a number, and the company names the three states it does not serve — Alabama, Louisiana and Mississippi — instead of the usual "select states" that tells you nothing. Free shipping, unlimited provider messaging and a 90-day money-back guarantee are stated terms, and if a clinician reads your intake and decides you are not a candidate, you are not charged. Both molecules come as a weekly injection or as a tablet at the same price, which is a genuinely rare needle-free option, and there is a separate low-dose microdose line for people who react badly to a full dose. The worse thing is what the advertised price is. "As low as $199/mo" for semaglutide and "$299/mo" for tirzepatide are the twelve-month rungs — not introductory rates, not a sale, but the rate you get if you prepay a year — and the site's own pricing data is built that way, with each product carrying its longest-term rung as the price it displays. Paying by the month costs $349 for semaglutide and $399 for tirzepatide. The prepay tiers are also a lump sum rather than a cheaper monthly bill: the $199 year is $2,388 charged on day one, the $299 tirzepatide year is $3,588, and each term auto-renews for the same amount unless you stop it. Financing appears on the site only once the term exceeds a month, which is another way of saying it appears only on the plans that need it. Two smaller things are worth knowing before you commit. The microdose line is not a budget line: it costs exactly the same as the full dose at every shared term and has a higher floor — $229 against $199 on semaglutide, $319 against $299 on tirzepatide — because it stops at eight months rather than twelve, so you pay more and get less drug. And the brand-name products here are a listing rather than a lane: Ozempic, Wegovy, Mounjaro, Zepbound and both brand pills carry no purchasable price, the two pills are marked out of stock, and the one priced brand path is a $49/mo membership plus a medication cost that is published nowhere. Watch the comparison table on the site too — the $250 consult, $100/mo follow-ups, $50/mo messaging and $350+/mo medication in it are what SkinnyRx says care costs elsewhere, not its own fees, and it does not say so plainly. There is also a disclosure that belongs on the record and is not a price question. FDA issued Lean Rx, Inc. dba SkinnyRx a warning letter in February 2026. It is in FDA's own searchable warning-letter database, where you can read it yourself; we link the index rather than the individual letter because FDA re-issues those URLs. We are not characterizing what it says — that is FDA's document, not ours — and we have not removed the company from this ranking or changed its Match Score because of it. What we will not do is sell you a click without telling you it exists. Worth choosing if a tablet route matters to you, you want the whole price grid visible before you start, and you have checked which term the number you are looking at belongs to. Skip it if $349 a month is out of range and a year up front is not an option, because that is the choice this pricing structure actually offers.